Genetic testing of cancer susceptibility genes is now widely applied in clinical practice to
predict risk of developing cancer. In general, sequence‐based testing of germline DNA is used …

The Breast Cancer Association Consortium (BCAC) has been established to conduct combined
case-control analyses with augmented statistical power to try to confirm putative genetic …

To date, more than 300 distinct small deletions, insertions and point mutations, mostly
leading to premature termination of translation1, have been reported in the breast/ovarian-cancer …

As genetic testing for predisposition to human diseases has become an increasingly
common practice in medicine, the need for clear interpretation of the test results is apparent. …

Germline BRCA1 mutations predispose to breast cancer. To identify genetic modifiers of this
risk, we performed a genome-wide association study in 1,193 individuals with BRCA1 …

We applied a novel method to detect single or multiple exon deletions and amplifications in
the BRCA1 gene. The test, called multiplex ligation-dependent probe amplification (MLPA), …

Breast cancer is the most common cancer among women. To date, 22 common breast cancer
susceptibility loci have been identified accounting for ∼8% of the heritability of the disease…

Background Li–Fraumeni syndrome (LFS) is a rare autosomal dominant cancer predisposition
syndrome. Most families fulfilling the classical diagnostic criteria harbour TP53 germline …

Estrogen receptor (ER)-negative breast cancer shows a higher incidence in women of African
ancestry compared to women of European ancestry. In search of common risk alleles for …

Background Lynch syndrome is caused by germline mutations in MSH2, MLH1, MSH6, and
PMS2 mismatch-repair genes and leads to a high risk of colorectal and endometrial cancer. …